LONG-TERM STABILIZATION OF KIDNEY FUNCTION REGARDLESS OF BASELINE eGFR AND UPCR IN PATIENTS WITH IgA NEPHROPATHY: SUBGROUP ANALYSES FROM THE ZIGAKIBART PHASE I/II TRIAL

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/21d19542f55c9a5bc2dbe336b13a7dd6.pdf
LONG-TERM STABILIZATION OF KIDNEY FUNCTION REGARDLESS OF BASELINE eGFR AND UPCR IN PATIENTS WITH IgA NEPHROPATHY: SUBGROUP ANALYSES FROM THE ZIGAKIBART PHASE I/II TRIAL

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Jonathan
Barratt
Jonathan Barratt jb81@leicester.ac.uk University of Leicester The Mayer IgA Nephropathy Laboratories Leicester United Kingdom * The John Walls Renal Unit Leicester General Hospital Leicester United Kingdom
Eun Young Lee eylee@sch.ac.kr Soonchunhyang University Hospital Cheonan College of Medicine Cheonan-si Korea (Republic of) -
Hamid Moradi hamid.moradi@novartis.com Novartis US Medical Affairs East Hanover United States -
William T Smith william-6.smith@novartis.com Novartis Clinical Development East Hanover United States -
Cong Lin cong-1.lin@novartis.com Novartis Analytics Shanghai China -
Laura Kooienga lkooienga@cokidneycare.com Colorado Kidney Care Research Department Denver United States -